Terms of Service

By accessing and using the Concurrent Biologics Registry website ("the Website"), all visitors agree to be bound by these Terms of Service. If these terms are not acceptable, the Website should not be used.

The Concurrent Biologics Registry is a quality assurance and practice improvement resource that aggregates de-identified patient case data about concurrent biologic therapy outcomes contributed by healthcare professionals worldwide.

The Registry is intended to support informed clinical decision-making by consolidating real-world evidence on concurrent biologic therapy. The data, statistics, and visualizations presented on the Website are for informational and quality assurance purposes only and should not be used as a substitute for independent professional clinical judgment.

Use of this Website does not establish a doctor-patient relationship, a clinical care relationship, or any professional relationship between any user and the Concurrent Biologics Registry or its operators. The Registry does not provide clinical care or medical advice.

The case submission form is intended for use by licensed healthcare professionals, including physicians and clinical staff involved in the management of patients receiving concurrent biologic therapy.

By submitting a case, submitters represent and warrant that they are qualified healthcare professionals authorized to access and share the de-identified clinical data contained in their submission. As the Registry operates as a quality assurance tool collecting only de-identified, non-identifiable clinical data, research ethics board approval is not required for case submission.

The Registry is designed so that personally identifiable health information is never collected. All patient data submitted must be fully de-identified prior to submission. Submitters must not include patient names, dates of birth, medical record numbers, addresses, treatment dates, or any other information that could directly or indirectly identify a patient.

The responsibility for ensuring proper de-identification rests with the submitter. Submissions undergo quality review, during which any data that appears to contain identifiable patient information will be flagged and removed.

All submissions are subject to quality review by Registry administrators for completeness, clinical plausibility, and consistency. The Registry reserves the right to approve, reject, or remove any submission at its sole discretion without obligation to provide a reason.

By submitting a case, the submitter grants the Registry a perpetual, non-exclusive, royalty-free, worldwide license to use, aggregate, analyze, publish, and display the submitted data for quality assurance, practice improvement, and registry purposes. Contributors are acknowledged for their submissions but do not retain editorial control over submitted case data once it is included in the Registry dataset.

Submitters are responsible for the accuracy and completeness of all data submitted to the Registry.

Submissions undergo quality review for completeness, clinical plausibility, and consistency. However, the Registry does not independently verify the clinical accuracy of individual patient outcomes. No warranty is made regarding the accuracy, completeness, or reliability of any data contained in the Registry.

All content on this Website, including text, design elements, graphics, logos, data visualizations, and aggregate data presentations, is the property of the Concurrent Biologics Registry and is protected under Canadian copyright law. Reproduction, distribution, or modification of any content without prior written consent is prohibited.

The Website is provided on an "as is" and "as available" basis. There is no guarantee that the Website will be available at all times, and access may be interrupted for maintenance, updates, or other reasons without notice.

The Website may contain links to third-party websites for informational purposes. The Concurrent Biologics Registry is not responsible for the content, accuracy, or privacy practices of any external websites and does not endorse the information or services offered by third parties.

To the fullest extent permitted by applicable law, the Concurrent Biologics Registry, its operators, contributors, and affiliates shall not be liable for any direct, indirect, incidental, consequential, or special damages arising from:

• Use of or inability to use the Website.
• Reliance on any data, information, statistics, or visualizations provided on the Website.
• Any clinical decisions made based on Registry data.
• Any breach of de-identification responsibility by a submitter.

Submitters agree to indemnify and hold harmless the Concurrent Biologics Registry, its operators, and affiliates from any claims, damages, losses, or liabilities arising from their submissions, including but not limited to claims related to inadequate de-identification of patient data, unauthorized data submission, or submission of inaccurate data.

All users acknowledge that the Registry is a quality assurance resource and that any clinical decisions remain the sole responsibility of the treating healthcare professional. Users who rely on Registry data in clinical practice agree to indemnify and hold harmless the Registry, its operators, and affiliates from any claims arising from clinical decisions informed by Registry data.

These Terms of Service are governed by and construed in accordance with the laws of the Province of Ontario and the applicable federal laws of Canada. Any disputes arising from the use of this Website shall be subject to the exclusive jurisdiction of the courts of Ontario.

These Terms of Service may be updated at any time without prior notice. Continued use of the Website following any changes constitutes acceptance of the revised terms. The "Last updated" date at the top of this page indicates when the most recent changes were made.

For questions regarding these Terms of Service, the Registry may be contacted through the contact page.